mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-07 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-07 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-07 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-07 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
5e-07 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
7e-07 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-07 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
9e-07 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
1e-06 |